Plaisance Capital Management: Funding, Team & Investors | Startup Intros

Loading organizations...

Plaisance Capital Management: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 16, 2025	BlossomHill Therapeutics	$84.0M Series B Extension	Brahma Capital, Vish Sridharan	Cormorant Asset Management, OrbiMed, Vivo Capital
Sep 30, 2025	Full-Life Technologies	$77.0M Life Technologies - Debt / Series C	Wei Shen	Chengwei Capital, Lapam Capital, Prosperity7 Ventures, Sequoia Capital, Summer Capital, TruMed Investment
May 2, 2024	Reunion Neuroscience	$103.0M Series A	Ansbert Gadicke, Natalie Sacks	Arkin Bio Ventures, FemHealth Ventures, Mitsui & Co. Global Investment, Palo Santo
Jan 1, 2024	BlossomHill Therapeutics	$100.0M Series B	Sundeep Agrawal	General Catalyst, OrbiMed, Sofinnova Investments, Bihua Chen, H&D Asset Management, Hercules BioVentures Partners, Timothy Stubbs
Sep 1, 2023	Corsair Pharma	$23.0M Series B	New Rhein Healthcare Investors	Junson Capital, Midas Capital, Primavera Capital Group
Jul 1, 2023	Smartlens	$6.0M Series A	Ambit Health Ventures	Blackwood Healthcare Breakthroughs, Connecticut Innovations, 3E Bioventures Capital, Boutique Venture Partners, Graphene Ventures, Sophia Innovation Capital, Stanford University, WS Investments
Sep 16, 2021	IASO Biotherapeutics	$108.0M Series C	Wei Ying	CCB International, China Everbright